
IPCIQ
Healthcare · Biotechnology · $5.0M market cap
$0.15000.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 17, 2023 | Time not confirmed | — | -0.06 | — |
| Jul 17, 2023 | Time not confirmed | — | -0.00 | — |
| Feb 27, 2023 | Time not confirmed | — | -0.03 | — |
| Oct 17, 2022 | Time not confirmed | — | -0.01 | — |
| Jul 21, 2022 | Time not confirmed | — | -0.03 | — |
| Apr 15, 2022 | Time not confirmed | — | -0.03 | — |
| Oct 18, 2021 | Time not confirmed | — | -0.04 | — |
| Jul 16, 2021 | Time not confirmed | — | -0.04 | — |
| Apr 14, 2021 | Time not confirmed | — | -0.04 | — |
| Oct 16, 2020 | Time not confirmed | — | 0.04 | — |
| Jul 16, 2020 | Time not confirmed | — | -0.04 | — |
| Mar 2, 2020 | Time not confirmed | — | -0.06 | — |
| Oct 11, 2019 | Time not confirmed | — | -0.07 | — |
Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular,…
| Time not confirmed |
| — |
| -0.10 |
| — |
| Apr 16, 2019 | Time not confirmed | — | -0.02 | — |
| Feb 22, 2019 | After the close | -0.30 | -0.67 | -123.3% |
| Oct 15, 2018 | After the close | -0.40 | -0.91 | -127.5% |
| Jul 16, 2018 | After the close | -0.70 | -0.70 | 0.0% |
| Apr 16, 2018 | After the close | -0.50 | -0.90 | -80.0% |
| Feb 16, 2018 | Time not confirmed | — | -0.80 | — |